F
Francesco Boccardo
Researcher at University of Genoa
Publications - 279
Citations - 18535
Francesco Boccardo is an academic researcher from University of Genoa. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 43, co-authored 262 publications receiving 16582 citations. Previous affiliations of Francesco Boccardo include National Cancer Research Institute.
Papers
More filters
Journal ArticleDOI
Lymphoscintigraphic evaluation of congenital lymphedema of the newborn.
Carlo Bellini,Cesare Arioni,Massimo Mazzella,Corradino Campisi,G. Taddei,Francesco Boccardo,Giovanni Serra +6 more
TL;DR: This case confirms the utility of lymphoscintigraphy in providing important physiologic and anatomic information for presurgical planning and should be considered a valuable diagnostic tool, especially in newborns, in whom conventional contrast lymphoangiography is difficult to perform.
Journal ArticleDOI
Use of metronomic chemotherapy in oncology: results from a national Italian survey.
Elena Collovà,Federica Sebastiani,Elisabetta De Matteis,Daniele Generali,Gaetano Aurilio,Francesco Boccardo,Sergio Crispino,Giorgio Cruciani +7 more
TL;DR: The sample of oncologists who participated in the survey is small but it appears to be representative of the Italian medical oncology community, and the answers to the questionnaire indicate a significant interest in metronomic chemotherapy, which is apparently widely prescribed.
Journal ArticleDOI
Suramin/epidoxorubicin association in hormone-refractory prostate cancer: preliminary results of a pilot phase II study.
Loredana Miglietta,Luciano Canobbio,Cristina Granetto,Maria O. Vannozzi,Mauro Esposito,Francesco Boccardo +5 more
TL;DR: The results achieved in this study seem to suggest that this regimen cannot be recommended for use in the treatment of metastatic hormone-refractory prostate cancer, and significant toxicity of suramin/epidoxorubicin association is shown.
Journal ArticleDOI
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-α
Luciano Canobbio,Alessandra Rubagotti,Loredana Miglietta,Daniela Cannata,Antonio Curotto,Domenico Amoroso,Francesco Boccardo +6 more
TL;DR: A group of 73 patients with advanced renal cell carcinoma, treated in different phase II trials with interferon α and/or interleukin-2, have been evaluated to identify potential baseline prognostic factors predicting their survival.
Journal ArticleDOI
Management of young women with early breast cancer
Francesca Poggio,Matteo Lambertini,Claudia Bighin,Benedetta Conte,Eva Blondeaux,Alessia D'Alonzo,Chiara Dellepiane,Francesco Boccardo,Lucia Del Mastro +8 more
TL;DR: A perspective on the many challenges associated with treatment of young women with early breast cancer is provided, highlighting the paucity of age-specific results about the available genomic signatures, the groundbreaking landscape of adjuvant endocrine therapy and the relevant issue of the fertility preservation.